S&P 500 7,551.81 −0.45%
Nasdaq 25,978.42 −0.01%
S&P/TSX 35,491.27 −0.26%
Apple 332.41 +0.32%
Nvidia 213.90 +0.82%
Microsoft 490.30 −1.37%
Shopify 181.77 +0.54%
Royal Bank 283.06 −0.40%
CAD/USD 0.7148 −0.47%
PRE-MKT · 08:20 ET
Market ClerkRecap
Thu Sep 17 · pre-market3 signals today312 insider buys this week · $295.5MCIRO short report next: Sep 30The week ahead

HCAT

Health Catalyst, Inc.
NASDAQ · TECHNOLOGY · SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC.
1.73
+0.01 +0.58%
USD · Sep 17, 08:21 a.m. ET

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

Who holds it

SEC 13F · LATEST QUARTER PER FUND
None of the 15 tracked funds disclose HCAT in their latest 13F. The funds we follow.

13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.

Stakes of 5% or more

SCHEDULE 13D / 13G · LATEST PER HOLDER · TWO YEARS
Palogic Value Management, LP and 3 related7.1%
SCHEDULE 13D/A · filed Sep 8 · activist · EDGAR ↗

“Item 4 is hereby amended and supplemented as follows: "On September 4, 2026, Palogic Value Management sent a letter (the "September 2026 Letter") to the Board of Directors of the Issuer following the Issuer's VitalWare sale. In the September 2026 Letter, Palogic Value Management applauded the sale a…”

A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.

Watch HCAT. Know when insiders buy.
One email the day a filing lands. Free.